Unfair competition governs the interaction of pCPI-17 with myosin phosphatase (PP1-MYPT1)

Elife. 2017 Apr 7:6:e24665. doi: 10.7554/eLife.24665.

Abstract

The small phosphoprotein pCPI-17 inhibits myosin light-chain phosphatase (MLCP). Current models postulate that during muscle relaxation, phosphatases other than MLCP dephosphorylate and inactivate pCPI-17 to restore MLCP activity. We show here that such hypotheses are insufficient to account for the observed rapidity of pCPI-17 inactivation in mammalian smooth muscles. Instead, MLCP itself is the critical enzyme for pCPI-17 dephosphorylation. We call the mutual sequestration mechanism through which pCPI-17 and MLCP interact inhibition by unfair competition: MLCP protects pCPI-17 from other phosphatases, while pCPI-17 blocks other substrates from MLCP's active site. MLCP dephosphorylates pCPI-17 at a slow rate that is, nonetheless, both sufficient and necessary to explain the speed of pCPI-17 dephosphorylation and the consequent MLCP activation during muscle relaxation.

Keywords: CPI-17; biochemistry; cell biology; human; mouse; myosin phosphatase; smooth muscle contraction/relaxation; unfair competition.

MeSH terms

  • HEK293 Cells
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Muscle Proteins
  • Myosin-Light-Chain Phosphatase / metabolism*
  • Phosphoprotein Phosphatases / metabolism*
  • Phosphorylation
  • Protein Processing, Post-Translational

Substances

  • Intracellular Signaling Peptides and Proteins
  • Muscle Proteins
  • PPP1R14A protein, human
  • Phosphoprotein Phosphatases
  • Myosin-Light-Chain Phosphatase
  • PPP1R12A protein, human